Literature DB >> 31750123

Outcomes of Using Otoendoscopy During Surgery for Cholesteatoma.

Alaa Eldin M Elfeky1, Alaa O Khazbzk1, Wail F Nasr1, Tarek A Emara1, Mohamed W Elanwar1, Hazem S Amer1, Yasser A Fouad1.   

Abstract

To determine the impact of using otoendoscopy at the time of primary surgery of cholesteatoma in identifying hidden "cholesteatoma remnant". Study was prospective study. Setting was University tertiary care hospital. One hundred fifty, patients diagnosed clinically and by CT as having cholesteatoma, have been operated. 64 patients operated by using canal up technique and 86 patients operated by using canal down technique. Once all visible cholesteatoma was removed with standard microscopic techniques, otoendoscopy was utilized in every patient to identify any hidden "cholesteatoma remnant". Despite apparent total microscopic eradication of cholesteatoma of the operated cases, otoendoscopy at time of primary surgery revealed an overall incidence of hidden cholesteatoma remnants of 18%. The incidence of hidden cholesteatoma remnants identified by otoendoscopy was 23% in the canal up group and 14% in the canal down group. Otoendoscopy should be used as an adjunct with standard microscopic technique to identify hidden cholesteatoma remnants during surgery of cholesteatoma. © Association of Otolaryngologists of India 2017.

Entities:  

Keywords:  Canal down; Canal up; Cholesteatoma; Cholesteatoma remnant; Otoendoscopy

Year:  2017        PMID: 31750123      PMCID: PMC6841777          DOI: 10.1007/s12070-017-1084-7

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  17 in total

1.  Value of ear endoscopy in cholesteatoma surgery.

Authors:  M Badr-el-Dine
Journal:  Otol Neurotol       Date:  2002-09       Impact factor: 2.311

2.  Residual cholesteatoma: prevalence and location. Follow-up strategy in adults.

Authors:  L Gaillardin; E Lescanne; S Morinière; J-P Cottier; A Robier
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2011-09-28       Impact factor: 2.080

3.  Sinus tympani endoscopic anatomy.

Authors:  Fatthi Abdel Baki; Mohammed Badr El Dine; Ibrahim El Saiid; Moustafa Bakry
Journal:  Otolaryngol Head Neck Surg       Date:  2002-09       Impact factor: 3.497

4.  Endoscopic management of acquired cholesteatoma: our experience.

Authors:  Livio Presutti; Daniele Marchioni; Francesco Mattioli; Domenico Villari; Matteo Alicandri-Ciufelli
Journal:  J Otolaryngol Head Neck Surg       Date:  2008-08

5.  Extensive cholesteatoma: long-term results of three surgical techniques.

Authors:  M Nyrop; P Bonding
Journal:  J Laryngol Otol       Date:  1997-06       Impact factor: 1.469

6.  The use of middle ear endoscopy: has residual cholesteatoma been eliminated?

Authors:  M W Yung
Journal:  J Laryngol Otol       Date:  2001-12       Impact factor: 1.469

7.  Modified Bondy's technique: refinements of the surgical technique and long-term results.

Authors:  Mario Sanna; Ammar Al Lawati Facharzt; Alessandra Russo; Lorenzo Lauda; Enrico Pasanisi; Andrea Bacciu
Journal:  Otol Neurotol       Date:  2009-01       Impact factor: 2.311

8.  Otoendoscopy in cholesteatoma surgery of the middle ear: what benefits can be expected?

Authors:  Stephane Ayache; Blaise Tramier; Vladimir Strunski
Journal:  Otol Neurotol       Date:  2008-12       Impact factor: 2.311

9.  Residual cholesteatoma: incidence and localization in canal wall down tympanoplasty with soft-wall reconstruction.

Authors:  Shin-ichi Haginomori; Atsuko Takamaki; Ryuzaburo Nonaka; Hiroshi Takenaka
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2008-06

Review 10.  Results of endoscopic middle ear surgery for cholesteatoma treatment: a systematic review.

Authors:  L Presutti; F M Gioacchini; M Alicandri-Ciufelli; D Villari; D Marchioni
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

View more
  1 in total

1.  Assessing the Prognostic Value of the ChOLE Classification in Predicting the Severity of Acquired Cholesteatoma.

Authors:  Maura C Eggink; Maarten J F de Wolf; Fenna A Ebbens; Frederik G Dikkers; Erik van Spronsen
Journal:  Otol Neurotol       Date:  2022-04-01       Impact factor: 2.311

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.